ClinicalTrials.gg
RecruitingNCT07235657Updated Nov 5, 2026

AI-Assisted Interpretation of Cardiac CT in the Emergency Department

An interventional study of Angiomics AI-based Coronary CT Interpretation Tool and Standard CCTA Interpretation without AI in Chest Pain, Acute Coronary Syndrome and Coronary Artery Disease, sponsored by Yonsei University. Recruiting at 1 site in South Korea. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Yonsei University · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 10 months later.
Updated Nov 5, 2026Now RecruitingSite recruiting status changed+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
620
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Chest Pain with a site in Korea, Republic of — 3 open to participants now, 4 under way, none of them phase 3. Chest Pain · Korea, Republic of.

Started
2025
with 1 other
No phase
9 of 10
3 open now
Registered
9th of 10
by date
Lead sponsor
1 of 10
Yonsei University

Among the 10 studies in Chest Pain with a site in Korea, Republic of, this one is one of 2 that started in 2025, is one of 9 with no phase, and was the 9th registered.

Chest Pain

389 studies on the registry are indexed under Chest Pain; 65 are open to participants now.

Browse Chest Pain studies →

Open to participants now

3 of the 10 studies in Chest Pain with a site in Korea, Republic of are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 43 Chest Pain studies recruiting now, 30 (70%) set no upper age limit and 6 (14%) stop at 75 or younger; 5 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Chest Pain with a site in Korea, Republic of, or all of them as a file.
02

Study summary

This prospective, pragmatic, randomized controlled trial is designed to evaluate the impact of an artificial intelligence (AI)-based coronary computed tomography angiography (CCTA) interpretation tool (Angiomics) on emergency physicians' diagnostic performance and clinical decision-making in patients presenting with acute chest pain.

CCTA is a critical diagnostic modality for suspected acute coronary syndrome (ACS) in the emergency department (ED). Accurate interpretation often requires experienced radiologists, who may not always be available, particularly during off-hours. The introduction of AI-based interpretation tools into clinical workflow has the potential to enhance diagnostic accuracy, increase physician confidence, reduce delays in decision-making, and improve efficiency of resource utilization. However, evidence regarding the real-world effectiveness of such AI tools in the ED setting remains limited.

Eligible participants will include adults aged 18 years or older presenting to the ED with chest pain and classified as intermediate risk (HEART score 4-6). Participants will be randomized into two groups: (1) AI-assisted CCTA interpretation, in which emergency physicians interpret scans with access to AI results; and (2) standard interpretation, in which emergency physicians interpret CCTA without AI support. In both groups, physicians will document the presence of stenosis in the four major coronary arteries (LM, LAD, LCX, RCA).

After informed consent, participants are randomised in a 1:1 ratio before CCTA acquisition to AI-assisted or standard CCTA interpretation. Diagnostic confidence is recorded using four categories: very high, high, moderate and low. The enrolment target is 620 participants, with 310 participants per group. This is a single-centre trial conducted at Severance Hospital, Seoul, Republic of Korea.

The primary outcome is the negative predictive value (NPV) of CCTA interpretation at the patient level, comparing AI-assisted versus standard interpretations against the reference standard of blinded consensus readings by board-certified radiologists. Secondary outcomes include per-patient diagnostic performance (sensitivity, specificity, PPV and AUROC), per-vessel diagnostic performance, emergency physician diagnostic confidence and protocol deviation rate. Other outcomes include cardiology consultation rate and time to disposition decision.

Enrollment and follow-up will be conducted at Severance Hospital over a 24-month period following IRB approval. The results are expected to provide evidence for the clinical utility and effectiveness of AI-based CCTA interpretation in the ED and to guide integration of AI into emergency care in order to optimize patient outcomes and healthcare efficiency.

Read the detailed description

This study is a prospective, pragmatic, randomized controlled trial designed to evaluate the impact of an artificial intelligence (AI)-based coronary computed tomography angiography (CCTA) interpretation tool (Angiomics) on the diagnostic accuracy, confidence, and decision-making of emergency physicians in patients presenting with acute chest pain.

Background and Rationale CCTA is widely used in the emergency department (ED) for patients presenting with acute chest pain or suspected acute coronary syndrome (ACS). It provides rapid and precise visualization of the coronary arteries and assists emergency physicians in making time-sensitive clinical decisions. However, interpretation of CCTA requires specialized training and experience, which may not always be available, particularly during nights or in resource-limited settings. This limitation can delay diagnosis and treatment, potentially leading to adverse patient outcomes.

Recent advances in AI technology have enabled the development of automated tools capable of analyzing CCTA images and identifying clinically significant findings such as coronary artery stenosis and myocardial ischemia. These tools have the potential to support emergency physicians by improving diagnostic accuracy, reducing interpretation time, enhancing physician confidence, and optimizing the use of healthcare resources. Despite these advantages, the influence of AI-based interpretation on real-world ED clinical workflows and physician decision-making remains insufficiently studied.

The present trial is designed to address this knowledge gap by evaluating whether the integration of an AI-based CCTA interpretation tool improves emergency physician diagnostic performance and clinical confidence, and whether such improvements translate into more reliable decision-making in the ED.

Study Design This study will employ a prospective, pragmatic, randomized controlled design. Eligible participants will be adults aged 18 years or older presenting to the ED with chest pain and classified as intermediate risk according to the HEART score (4-6 points). Participants are randomised after informed consent and before CCTA acquisition. Allocation is 1:1 between the AI-assisted interpretation group and the standard interpretation group.

  1. AI-assisted group (Experimental Arm): Emergency physicians interpret CCTA scans with access to AI results provided by the Angiomics software.
  2. Standard interpretation group (Active Comparator Arm): Emergency physicians interpret CCTA scans without access to AI results.

All physicians will evaluate stenosis in the four major coronary arteries (left main, left anterior descending [LAD], left circumflex [LCX], and right coronary artery [RCA]) and record their findings using a standardized format (Yes/No/Non-diagnostic/Other findings). Emergency physicians record diagnostic confidence using four categories: very high, high, moderate and low.

Reference Standard The reference standard for diagnostic performance will be the blinded consensus interpretation of board-certified radiologists specialized in thoracic imaging. Previous studies have demonstrated concordance of 98-99% between expert radiologist consensus and invasive coronary angiography, supporting the validity of this approach.

Outcomes The primary outcome is the negative predictive value (NPV) of CCTA interpretation at the patient level, comparing AI-assisted versus standard interpretations. Patient-level outcomes will be derived by aggregating findings across the four major coronary arteries.

Secondary outcomes include:

  • Per-patient diagnostic performance: sensitivity, specificity, PPV and AUROC
  • Per-vessel diagnostic performance for LM, LAD, LCx and RCA: sensitivity, specificity, PPV, NPV and AUROC
  • Emergency physician diagnostic confidence (four categories)
  • Protocol deviation rate Other outcomes include cardiology consultation rate and time to disposition decision.

Reader Experience and Image Quality Emergency physician imaging training, prior CCTA interpretation experience and years of clinical experience are collected. Image quality is assessed by a radiologist blinded to AI outputs, emergency physician interpretations and allocation, and classified as Poor/Fair or Good/Excellent. These variables are considered in exploratory adjusted analyses.

Analysis Population and Preliminary Interpretation Exposure The primary analysis uses a modified intention-to-treat population, excluding participants whose emergency physician was exposed to a preliminary radiology interpretation before completing the study interpretation. AI processing failures remain in the assigned group. A sensitivity analysis includes participants with prior preliminary radiology exposure when both index and reference interpretations are available.

Sample Size and Statistical Analysis The original enrolment target was 552 participants, with 276 participants per group, allowing for 10% dropout. Following consultation with a statistician, the target was revised using a pooled negative diagnosis rate of 64.9% to obtain 181 negative interpretations per group. Allowing for 10% dropout, the required sample size was 181/(0.649 × 0.90), rounded up to 310 participants per group, for a total of 620 participants. The IRB approved the sample-size amendment on 20 July 2026. The persons responsible for the sample-size decision did not have access to group-specific interim results.

An interim analysis was conducted on 8 September 2026. Type I error is controlled using the prespecified O'Brien-Fleming alpha-spending approach, accounting for the actual information fraction.

Diagnostic performance (sensitivity, specificity, PPV, NPV, accuracy) will be compared using chi-square or Fisher's exact tests as appropriate. Agreement between physician and radiologist consensus readings will be assessed using Cohen's Kappa. All statistical tests will be two-sided.

Data Collection and Confidentiality Data will be collected within the routine clinical workflow and stored in a secure, de-identified format according to institutional policies and national privacy regulations. Only authorized investigators will have access to the data. Data will be stored for three years after study completion before secure disposal.

Safety and Monitoring This trial poses minimal risk to participants, as it involves no procedures outside of routine clinical care. No additional radiation, medications, or invasive interventions are introduced by study participation. The study principal investigator will monitor protocol adherence and data quality on an annual basis. The study is subject to continuing IRB review and institutional monitoring or audit in accordance with institutional procedures. The principal investigator is responsible for protocol adherence, data integrity and safety reporting.

Significance This study will provide evidence regarding the clinical utility of an AI-based CCTA interpretation tool in the ED. Findings are expected to clarify whether AI support improves diagnostic accuracy and physician confidence, and whether it can be effectively integrated into real-world emergency care. The results may inform best practices for the implementation of AI tools to optimize patient outcomes and resource utilization in acute care settings.

03

Conditions studied

  • Chest Pain
  • Acute Coronary Syndrome
  • Coronary Artery Disease

Keywords

  • Artificial Intelligence
  • Emergency Service, Hospital
  • Coronary Computed Tomography Angiography
04

Who can participate

The criteria were revised on the registry on Nov 5, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adults aged 18 years or older Patients presenting to the emergency department with acute chest pain or chest discomfort Patients assessed as intermediate risk (Heart Score 4-6) Patients for whom CCTA was ordered by the treating physician as part of routine clinical care

Exclusion criteria

Exclusion Criteria:

Prior history of coronary revascularization (coronary artery bypass graft surgery or stent placement) Presence of intracardiac metallic devices such as pacemaker or prosthetic heart valves to contrast media (e.g., contrast allergy, severe renal impairment with \< 30 mL/min/1.73 m²) Patients unable to cooperate (e.g., severe anxiety, non-cooperation) Non-diagnostic CCTA images are identified after image acquisition and handled according to the protocol-defined analysis exclusions.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
620 participants (estimated)

Study arms

  • Experimental
    AI-assisted CCTA interpretation

    Emergency physicians interpret coronary CT angiography (CCTA) with the assistance of an AI-based interpretation tool (Angiomics). Physicians record stenosis presence in four major coronary vessels and rate diagnostic confidence using a four-category confidence rating: very high, high, moderate and low.

    Device: Angiomics AI-based Coronary CT Interpretation Tool

  • Active comparator
    Standard CCTA interpretation (without AI)

    Emergency physicians independently interpret coronary CT angiography (CCTA) without access to the AI-based interpretation tool. Physicians record stenosis presence in four major coronary vessels and rate diagnostic confidence using a four-category confidence rating: very high, high, moderate and low.

    Other: Standard CCTA Interpretation without AI

Interventions

  • DeviceAngiomics AI-based Coronary CT Interpretation Tool

    AI software integrated with the hospital PACS system to assist emergency physicians in interpreting coronary CT angiography (CCTA). The tool automatically analyzes stenosis in the left main, LAD, LCX, and RCA, and physicians use the results to guide their interpretation.

  • OtherStandard CCTA Interpretation without AI

    Emergency physicians independently interpret coronary CT angiography (CCTA) without access to the AI tool. Physicians evaluate stenosis in the left main, LAD, LCX, and RCA, and report diagnostic confidence using a four-category confidence rating: very high, high, moderate and low.

06

What researchers measure

Primary outcomes

  1. Per-patient negative predictive value of emergency physician CCTA interpretation

    Negative predictive value is the number of true-negative patients divided by all patients classified as negative by the emergency physician, using blinded expert radiologist consensus as the reference standard. Significant coronary stenosis is defined as ≥50% luminal narrowing. A patient is classified as positive if at least one of the four major coronary vessels (LM, LAD, LCx or RCA) is positive, and as negative if all four vessels are negative. Negative predictive value is compared between the AI-assisted and standard interpretation groups.

    Time frame: During the initial emergency department visit, at the time of index CCTA interpretation.

Secondary outcomes

  1. Per-patient diagnostic performance

    Sensitivity, specificity, positive predictive value and area under the receiver operating characteristic curve of emergency physician interpretation, using blinded expert radiologist consensus as the reference standard. AUROC is calculated from binary stenosis classifications.

    Time frame: During the initial emergency department visit, at the time of index CCTA interpretation.

  2. Per-vessel diagnostic performance

    Sensitivity, specificity, positive predictive value, negative predictive value and AUROC for the LM, LAD, LCx and RCA, using blinded expert radiologist consensus as the reference standard.

    Time frame: During the initial emergency department visit, at the time of index CCTA interpretation.

  3. Emergency physician diagnostic confidence

    Distribution of four-category confidence ratings (very high, high, moderate and low), compared between randomised groups.

    Time frame: At completion of the emergency physician's index CCTA interpretation during the initial emergency department visit.

  4. Protocol deviation rate

    Proportion of randomised participants with a documented protocol deviation.

    Time frame: During the initial emergency department episode.

Other outcomes

  1. Cardiology consultation rate

    Proportion of participants receiving cardiology consultation during the initial emergency department episode.

    Time frame: During the initial emergency department episode.

  2. Time to disposition decision

    Elapsed time from emergency department arrival to the disposition decision.

    Time frame: From emergency department arrival to the disposition decision during the initial emergency department episode.

07

Study locations

1 of 1 sites recruiting
  • Yonsei University College of Medicine, Yonsei University Severance Hospital
    Seoul, South Korea
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Requests for de-identified individual participant data, a data dictionary and analysis code will be considered after publication of the primary results. Access is subject to IRB approval and applicable confidentiality requirements.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Jun 2027, 18 months after the start.

Of 85 non-industry interventional studies with no phase under Chest Pain, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 43. This study's planned 18 months is below that.

Counting every sponsor, half of 87 studies reached it within 23 months; a quarter within 9 and three quarters within 43.

Start moved once since we started tracking on Sep 25, 2026: Nov 2025 → Dec 2025, on Nov 5, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2025
First posted
Nov 19, 2025
StartActual
Dec 29, 2025was Nov 2025
Primary completionEst.
Jun 2027
CompletionEst.
Aug 2027
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 5, 2026
Sites
Yonsei University College of Medicine, Yonsei University Severance Hospital is now Recruiting
Nov 5, 2026
Start date
Nov 2025→Dec 29, 2025 (actual)
Nov 5, 2026
Enrollment
530→620
Nov 5, 2026
Eligibility
1 inclusion criterion added, 3 removed; 1 exclusion criterion added, 4 removed
What changed in the criteria
Inclusion criteria
  • RemovedAdults aged 18 years or older
  • RemovedPatients presenting to the emergency department with chest pain
  • RemovedPatients assessed as intermediate risk (Heart Score 4-6)
  • AddedAdults aged 18 years or older Patients presenting to the emergency department with acute chest pain or chest discomfort Patients assessed as intermediate risk (Heart Score 4-6) Patients for whom CCTA was ordered by the treating physician as part of routine clinical care
Exclusion criteria
  • RemovedPrior history of coronary revascularization (coronary artery bypass graft surgery or stent placement)
  • RemovedPresence of intracardiac metallic devices such as pacemaker or prosthetic heart valves
  • RemovedContraindications to contrast media (e.g., contrast allergy, severe renal impairment with eGFR < 30 mL/min/1.73 m²)
  • RemovedPatients unable to cooperate (e.g., severe anxiety, non-cooperation)
  • AddedPrior history of coronary revascularization (coronary artery bypass graft surgery or stent placement) Presence of intracardiac metallic devices such as pacemaker or prosthetic heart valves Contraindications to contrast media (e.g., contrast allergy, severe renal impairment with eGFR < 30 mL/min/1.73 m²) Patients unable to cooperate (e.g., severe anxiety, non-cooperation) Non-diagnostic CCTA images are identified after image acquisition and handled according to the protocol-defined analysis exclusions.
Nov 5, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore NPV of EM physician CCTA interpretation (AI vs No AI)Now Per-patient negative predictive value of emergency physician CCTA interpretationTime frame: During initial ED visit, at the time of CCTA interpretation → During the initial emergency department visit, at the time of index CCTA interpretation.
Nov 5, 2026
Secondary outcomes
6 added
What changed in the outcomes
  • AddedPer-patient diagnostic performanceTime frame: During the initial emergency department visit, at the time of index CCTA interpretation.
  • AddedPer-vessel diagnostic performanceTime frame: During the initial emergency department visit, at the time of index CCTA interpretation.
  • AddedEmergency physician diagnostic confidenceTime frame: At completion of the emergency physician's index CCTA interpretation during the initial emergency department visit.
  • AddedProtocol deviation rateTime frame: During the initial emergency department episode.
  • Addedother outcomeCardiology consultation rateTime frame: During the initial emergency department episode.
  • Addedother outcomeTime to disposition decisionTime frame: From emergency department arrival to the disposition decision during the initial emergency department episode.
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Not yet recruiting→Recruiting
    Yonsei University College of Medicine, Yonsei University Severance Hospital is now Recruiting
    Start date Nov 2025→Dec 29, 2025 (now actual)
    Enrollment 530→620
    Eligibility 1 inclusion criterion added, 3 removed; 1 exclusion criterion added, 4 removed
    What changed in the criteria
    Inclusion criteria
    • RemovedAdults aged 18 years or older
    • RemovedPatients presenting to the emergency department with chest pain
    • RemovedPatients assessed as intermediate risk (Heart Score 4-6)
    • AddedAdults aged 18 years or older Patients presenting to the emergency department with acute chest pain or chest discomfort Patients assessed as intermediate risk (Heart Score 4-6) Patients for whom CCTA was ordered by the treating physician as part of routine clinical care
    Exclusion criteria
    • RemovedPrior history of coronary revascularization (coronary artery bypass graft surgery or stent placement)
    • RemovedPresence of intracardiac metallic devices such as pacemaker or prosthetic heart valves
    • RemovedContraindications to contrast media (e.g., contrast allergy, severe renal impairment with eGFR < 30 mL/min/1.73 m²)
    • RemovedPatients unable to cooperate (e.g., severe anxiety, non-cooperation)
    • AddedPrior history of coronary revascularization (coronary artery bypass graft surgery or stent placement) Presence of intracardiac metallic devices such as pacemaker or prosthetic heart valves Contraindications to contrast media (e.g., contrast allergy, severe renal impairment with eGFR < 30 mL/min/1.73 m²) Patients unable to cooperate (e.g., severe anxiety, non-cooperation) Non-diagnostic CCTA images are identified after image acquisition and handled according to the protocol-defined analysis exclusions.
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore NPV of EM physician CCTA interpretation (AI vs No AI)Now Per-patient negative predictive value of emergency physician CCTA interpretationTime frame: During initial ED visit, at the time of CCTA interpretation → During the initial emergency department visit, at the time of index CCTA interpretation.
    Secondary outcomes 6 added
    What changed in the outcomes
    • AddedPer-patient diagnostic performanceTime frame: During the initial emergency department visit, at the time of index CCTA interpretation.
    • AddedPer-vessel diagnostic performanceTime frame: During the initial emergency department visit, at the time of index CCTA interpretation.
    • AddedEmergency physician diagnostic confidenceTime frame: At completion of the emergency physician's index CCTA interpretation during the initial emergency department visit.
    • AddedProtocol deviation rateTime frame: During the initial emergency department episode.
    • Addedother outcomeCardiology consultation rateTime frame: During the initial emergency department episode.
    • Addedother outcomeTime to disposition decisionTime frame: From emergency department arrival to the disposition decision during the initial emergency department episode.
    + 5 other changes: verification date, oversight details, description, arm descriptions and data sharing statement

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07235657
Lead sponsor
Yonsei University
Responsible party
Sponsor
First posted
Nov 19, 2025
Start date
Dec 29, 2025
Primary completion
Jun 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Nov 5, 2026

Study contacts

arom choi, MD
Contact
aromchoi@yuhs.ac
+82-2-2228-2465

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion